WMSA
NVO

Weiss Multi-Strategy Advisers’s Novo Nordisk NVO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-48,737
Closed -$5.04M – 323
2023
Q4 		$5.04M Sell
48,737
-6,565
-12% -$649K 0.12% 228
2023
Q3 		$5.03M Buy
55,302
+19,186
+53% +$1.69M 0.12% 229
2023
Q2 		$2.92M Sell
36,116
-114
-0.3% -$9.31K 0.06% 400
2023
Q1 		$2.88M Buy
+36,230
New +$2.57M 0.07% 360
2022
Q3 		– Sell
-11,936
Closed -$665K – 735
2022
Q2 		$665K Buy
+11,936
New +$662K 0.02% 526

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NVO Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Novo Nordisk (NVO) in Q1 2024, closing a stake of 48,737 shares — an estimated $5.04M sold.

Weiss Multi-Strategy Advisers first reported a position in NVO in Q2 2022 and held it in 5 quarters. The position peaked at $5.04M in Q4 2023. 1,744 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Novo Nordisk position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 48,737 Novo Nordisk shares in Q1 2024, an estimated $5.04M.
  • Weiss Multi-Strategy Advisers first reported a position in Novo Nordisk in Q2 2022 and held it in 5 quarters.
  • Weiss Multi-Strategy Advisers's Novo Nordisk position peaked at $5.04M in Q4 2023.
  • 1,744 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.